Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related MRNS
The Companies That Led 2017's Biotech Rally
40 Biggest Movers From Yesterday
2018 Strategic Outlook: Will Fortune Favor The Bold In Biotech? (Seeking Alpha)
Related ALK
The 10 Most Undervalued Stocks Kicking Off Earnings Season
Benzinga's Top Upgrades, Downgrades For January 10, 2018
And The Dividend Flow Turned Into A Flood, Part II (Seeking Alpha)

Analysts at Goldman Sachs downgraded LinkedIn Corp (NYSE: LNKD) from Buy to Neutral. The target price for LinkedIn has been raised from $162 to $203. LinkedIn shares rose 0.03 percent to $192.26 in pre-market trading.

Raymond James downgraded Alaska Air Group, Inc. (NYSE: ALK) from Strong Buy to Outperform. Alaska Air shares dropped 3.93 percent to close at $64.29 on Monday.

Analysts at RBC Capital downgraded Marinus Pharmaceuticals Inc (NASDAQ: MRNS) from Outperform to Sector Perform. Marinus Pharmaceuticals shares rose 0.652 percent to $1.63 in pre-market trading.

Analysts at Jefferies downgraded LinkedIn Corp (NYSE: LNKD) from Buy to Hold. LinkedIn shares rose 0.03 percent to $192.26 in pre-market trading.

Wells Fargo downgraded Hyatt Hotels Corporation (NYSE: H) from Outperform to Market Perform. Hyatt Hotels shares declined 1.54 percent to close at $46.77 on Monday.

Analysts at Stifel Nicolaus downgraded Navistar International Corp (NYSE: NAV) from Hold to Sell. Navistar shares declined 4.03 percent to $12.63 in pre-market trading.

Deutsche Bank downgraded Gulfport Energy Corporation (NASDAQ: GPOR) from Buy to Hold. Gulfport Energy shares dropped 1.74 percent to close at $32.12 on Monday.

Brean Capital downgraded Revance Therapeutics Inc (NASDAQ: RVNC) from Buy to Hold. Revance Therapeutics shares dipped 23.54 percent to $14.03 in pre-market trading.

Piper Jaffray downgraded LinkedIn Corp (NYSE: LNKD) from Buy to Neutral. LinkedIn shares rose 0.03 percent to $192.26 in pre-market trading.

Latest Ratings for MRNS

DateFirmActionFromTo
Aug 2016JefferiesMaintainsBuy
Jun 2016RBC CapitalDowngradesOutperformSector Perform
Jun 2016JefferiesMaintainsBuy

View More Analyst Ratings for MRNS
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (GPOR + ALK)

View Comments and Join the Discussion!